NCT02003144 2022-08-23An Open Label Extension Trial of Eculizumab in Relapsing NMO PatientsAlexion Pharmaceuticals, Inc.Phase 3 Completed119 enrolled 17 charts
NCT01892345 2019-06-26A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)Alexion Pharmaceuticals, Inc.Phase 3 Terminated143 enrolled 18 charts